Bo‐Syong Pan
-
- Cancer, Hypoxia, and Metabolism 3
-
- Ubiquitin and proteasome pathways 5
- Epigenetics and DNA Methylation 3
- Protein Degradation and Inhibitors 3
- Metabolism, Diabetes, and Cancer 3
-
- Cancer-related Molecular Pathways 3
-
- Fungal Biology and Applications 3
-
- Endoplasmic Reticulum Stress and Disease 2
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Bo‐Syong Pan
21 papers receiving 482 citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Cancer Research 108
- Molecular Biology 355
- Developmental Neuroscience 16
- Oncology 94
- Immunology 56
Countries citing papers authored by Bo‐Syong Pan
This map shows the geographic impact of Bo‐Syong Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo‐Syong Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo‐Syong Pan more than expected).
Fields of papers citing papers by Bo‐Syong Pan
This network shows the impact of papers produced by Bo‐Syong Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo‐Syong Pan. The network helps show where Bo‐Syong Pan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bo‐Syong Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 15 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 5 | |
| 7 | NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistancebreakdown → | 2023 | 121 |
| 8 | 2023 | 9 | |
| 9 | 2022 | 37 | |
| 10 | 2022 | 11 | |
| 11 | 2020 | 118 | |
| 12 | 2019 | 15 | |
| 13 | 2018 | 15 | |
| 14 | 2018 | 36 | |
| 15 | 2016 | 15 | |
| 16 | 2015 | 9 | |
| 17 | 2014 | 12 | |
| 18 | 2013 | 25 | |
| 19 | 2011 | 21 | |
| 20 | 2011 | 4 |
About Bo‐Syong Pan
Bo‐Syong Pan is a scholar working on Developmental Neuroscience, Toxicology and Cancer Research, having authored 21 papers that have together received 488 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), Cancer, Hypoxia, and Metabolism (3 papers), Epigenetics and DNA Methylation (3 papers), Protein Degradation and Inhibitors (3 papers), Fungal Biology and Applications (3 papers), Cancer-related Molecular Pathways (3 papers), Metabolism, Diabetes, and Cancer (3 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). The work is most often cited by research in Cancer Research (108 citations), Molecular Biology (355 citations) and Developmental Neuroscience (16 citations). Bo‐Syong Pan has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Hui‐Kuan Lin, Hongyu Li, Che-Chia Hsu, Bu‐Miin Huang, Danni Peng, Rajesh Manne, Asad Moten, Zhen Cai, Tingjin Chen and Zheng‐Yu Wang. Their work appears in journals such as Cell, Journal of Biological Chemistry and Nature Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.